Skip to Main Content

Paper Details

Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1.
J Virol
9
2021
Author NameAffiliation
Gary P KobingerCentre de Recherche en Infectiologie de l'Universite Laval/Centre Hospitalier de l'Universite Laval
  • 1 - 1

Datasets

Release 1.2